ESC 365 - DELIVER baseline and design

HFA Premium Access

DELIVER baseline and design

Session: Late-Breaking Trials - Pharmacological treatment I

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor S. Solomon (Boston, US)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

82 presentations

37 followers

4 more presentations in this session

Patiromer for the management of hyperkalemia in subjects receiving renin-angiotensin-aldosterone system inhibitor medications for heart failure with reduced ejection fraction

Speaker: Professor S. Anker (Berlin, DE)

DEFINE-HF and PRESERVED-HF: Dapagliflozin improves heart failure symptoms and physical limitations across the entire range of LVEF

Speaker: Doctor M. Kosiborod (Kansas City, US)

HELIOS-A: 18month Exploratory Cardiac Results from the Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

GALACTIC-HF - omecamtiv mecarbil in HFrEF and low blood pressure

Speaker: Professor M. Metra (Brescia, IT)

Access the full session

Late-Breaking Trials - Pharmacological treatment I

Speakers: Professor S. Solomon, Professor S. Anker, Doctor M. Kosiborod, Doctor P. Garcia-Pavia, Professor M. Metra

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources